Performance will remain intact for rest of the year, says Meghmani Organics

Meghmani Organics has seen good growth across all segments. Margins have improved on the back of higher product prices.

In an interview to CNBC-TV18, Kaushal Soparkar, MD of Meghmani Organics spoke about the results and his outlook for the company.

Soparkar said capacity utilisation raised to 85 percent from 65 percent earlier.

On expansion front, he said in basic chemicals we have announced three projects and we have planned an expansion in chloromethane segment.

He further said that the domestic business accounts for 48 percent of total revenue.

Talking about performance, he said it will remain intact for the rest of the year.

On future growth perspective, he said we are targeting to maintain EBITDA minimum of 20 percent and profit after tax (PAT) should remain between 8.5 and 9 percent going ahead.

We have seen an increase in prices of raw materials, he added.

Watch accompanying video for more details.